| ASML.AS | ASML Holding NV | 6.84% |
| ROP.SW | Roche Holding AG Ordinary Shares new | 3.36% |
| BHP.AX | BHP Group Ltd | 2.69% |
| NOVN.SW | Novartis AG Registered Shares | 2.31% |
| NOVO-B.CO | Novo Nordisk AS Class B | 2.16% |
| INVE B | Investor AB Class B | 2.05% |
| AZN.L | AstraZeneca PLC | 1.93% |
| BATS.L | British American Tobacco PLC | 1.87% |
| DTE.DE | Deutsche Telekom AG | 1.81% |
| ALV.DE | Allianz SE | 1.78% |
IVSI uses proprietary valuation models in researching large-cap companies in developed markets outside of North America, aiming for growth through fundamental analysis. The funds adviser uses proprietary research, valuation models, and its Intrinsic Value Stewardship (IVS) model to select stocks with strong return potential, considering factors like valuation, growth, profitability, and business strategy. The Fund is actively managed, typically holds at least 150 positions across multiple countries and sectors, but may concentrate more in certain holdings if justified by its research. The adviser sells positions if they no longer offer compelling investment opportunities or become too large relative to the portfolio.
Applied Finance IVS International Large ETF · Issued by Applied Finance
No recent news for IVSI. The ingest cron pulls every 15 minutes during market hours.